Selective inhibitor could reduce resistance to cancer therapies
A study has found a selective inhibitor for an enzyme that allows cancer cells to mutate and become resistant to treatments.
List view / Grid view
A study has found a selective inhibitor for an enzyme that allows cancer cells to mutate and become resistant to treatments.
A drug discovery platform for mental health treatment could also help to identify mechanisms for the treatment of substance use disorders.
A simple and direct method of introducing lipids into protein has been developed using palladium as a catalyst.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
New findings on dementia reveal that brain atrophy spreads via connected brain networks, rather than simply adjacent areas of the brain.
A team has used viral gene editing and CRISPR to form a system that marks tumours for destruction, potentially improving immunotherapies.
Cells containing Meflin play a role in restraining the progression of pancreatic cancer and could lead to new therapies against the disease.
Microglia brain immune cells are vital in conjunction with the APOE4 gene during the development of Alzheimer’s in mouse models, researchers have found.
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed to both detect and destroy RNA-based viruses in human cells.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.
Researchers have created an AI model that analyses the citations of studies, predicting their potential for eventual clinical application.
Scientists in the US have identified a particular bacterial strain, Segmented filamentous bacteria (SFB), that can prevent and cure rotavirus in mice.
A genetic mutation that causes idiopathic pulmonary fibrosis has been identified and could lead to a new therapeutic approach to treating the disease.
A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.